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We have previously identified poly(ADP-ribose) polymerase-1 (PARP-1) as a coactivator for the human T cell leukemia virus
type I (HTLV-I) transcription activator Tax. While PARP-1 is believed to contribute to DNA repair, PARP-1 has been described
as a coactivator for other transcription factors. Recent evidence suggests that PARP-1 forms complexes on cellular
promoters, so we investigated PARP-1 complexes on the HTLV-I Tax responsive elements (TxREs) using an end-blocked DNA
binding assay. We observed sequence-specific binding of PARP-1 to the TxREs. The DNA binding domain of PARP-1 was
fused to the transcriptional activation domain of VP16, and this fusion protein activated the HTLV-I promoter in a TxRE-
dependent manner. Internal, sequence-specific binding of PARP-1 to DNA provides a mechanism for transcriptional regu-
lation of the HTLV-I promoter. The mechanism of PARP-1 function in the HTLV-I system may have common mechanistic stepsINTRODUCTION
Human T cell leukemia virus type I (HTLV-I) is a retro-
virus that is associated with the development of adult T
cell leukemia and a neurodegenerative disease called
HAM/TSP (Sodroski, 1992). HTLV-I encodes for a tran-
scriptional activator protein called Tax that is required for
efficient viral replication (Chen et al., 1985). Tax has been
shown to activate transcription from the HTLV-I promoter
through three semiconserved, 21-bp repeats called Tax
responsive elements (TxREs) (Brady et al., 1987; Fuji-
sawa et al., 1986; Paskalis et al., 1986; Rosen et al., 1985;
Shimotohno et al., 1986). Located upstream from the start
site of transcription, the TxREs contain nonconsensus
cyclic AMP response elements (CREs) (Giam and Xu,
1989; Jeang et al., 1988), which are binding sites for the
CREB/ATF family of transcriptional activators (Hai et al.,
1989; Montminy and Bilezikjian, 1987). Tax does not bind
directly to the TxREs (Beimling and Moelling, 1989); how-
ever, Tax can interact with the CRE-binding proteins
(Armstrong et al., 1993; Franklin et al., 1993; Matthews et
al., 1992; Suzuki et al., 1993; Zhao and Giam, 1991, 1992).
Therefore Tax must activate transcription through pro-
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dressed at Institute of Molecular Medicine and Genetics, Medical107tein–protein interactions with cellular activators that bind
directly to the HTLV-I promoter.
We developed a Tax-responsive, in vitro transcription
assay reconstituted from purified recombinant basal
transcription factors and purified fractions from nuclear
extracts to study the mechanism of Tax activation (Ander-
son et al., 2000). This in vitro transcription system is
unique in that it is driven by a natural transcription factor
(Tax) recruited to the HTLV-I promoter through its natural
mechanism, that is, its interaction with CREB. Using this
system, we identified three coactivator fractions that
were required for Tax-stimulated transcription (Anderson
et al., 2000). Further purification and sequencing of one
of these fractions identified one coactivator to be poly-
(ADP-ribose) polymerase-1 (PARP-1). Significantly, we
confirmed that PARP-1 is a bona fide coactivator for Tax
in live cells by demonstrating that Tax function is in-
creased when PARP-1 is transiently expressed in an
embryonic fibroblast cell line from a PARP-1-deficient
mouse (Anderson et al., 2000).
PARP-1 is a 110-kDa protein that contains three major
domains, as follows: a DNA binding domain in the amino
terminus, an automodification domain in the central re-
gion, and a substrate binding/catalytic domain in the
carboxyl terminus. PARP-1 binds nonspecifically to DNA
breaks (single-strand nicks or double-strand breaks) and
catalyzes the transfer of ADP-ribose from NAD to nu-
clear proteins, with PARP-1 itself being a major target of
this modification (reviewed in Lindahl et al. 1995). DNAwith other cellular promoters, including the formation of ac
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affinity for DNA and subsequently is released from the
DNA (Satoh and Lindahl, 1992). PARP-1 has been impli-
cated as a critical factor for DNA repair, genomic stabil-
ity, cell death and apoptosis, and the repression of sister
chromatid exchange (de Murcia et al., 1997; Lindahl et
al., 1995; Simbulan-Rosenthal et al., 1998; Trucco et al.,
1998; Wang et al., 1995, 1997).
Using fusion proteins of GAL4 and transcriptional ac-
tivators, PARP-1 has been identified to be the coactivator
activity, PC1 (Meisterernst et al., 1997). Although the
mechanism of transcriptional coactivation by PARP-1 is
not well understood, PARP-1 was shown to exert its
effect after the binding of TFIID to the template (Meister-
ernst et al., 1997). In addition, this article demonstrated
that bacterially expressed full-length PARP-1, as well as a
truncation mutant containing only the DNA binding re-
gion (1–450), were both functional. PARP-1 has been
shown to interact and form complexes with certain DNA
elements including MCAT1 elements found in muscle-
specific genes (Butler and Ordahl, 1999), a region in the
Reg gene promoter (Akiyama et al., 2001), and the IUR
element in the CXCL1 gene (Nirodi et al., 2001). The
mechanism of PARP-1 function in the HTLV-I Tax system
may have steps in common with these cellular factors,
since we have now observed sequence-specific binding
of PARP-1 to the HTLV-I TxREs.
RESULTS
Induction of Tax-activated transcription by PARP-1
in vivo
We have previously demonstrated (Anderson et al.,
2000) that Tax activation of transcription is enhanced by
transient expression of human PARP-1 in a mouse PARP-
1-deficient cell line (PARP-1 /) (Wang et al., 1995).
Similar experiments in the Jurkat T cell line failed to
demonstrate an effect of transient PARP-1 expression,
most likely due to the high expression of PARP-1 in those
cells (data not shown). Therefore, to confirm the effects
of PARP-1 in cells that stably express PARP-1, we estab-
lished a PARP-1 / cell line (A4) that stably expresses
the cDNA for human PARP-1. This cell line expresses
40–50% of the PARP-1 protein levels seen in strain-
matched wild-type cells (the A4 cell line shown in Fig. 1A,
compared to PARP-1 /). As was observed with the
transient transfections, Tax showed greater activation of
the HTLV-I promoter (about fivefold in this experiment) in
cells that express PARP-1 (see Fig. 1B).
Coactivation of Tax-activated in vitro transcription
by full-length PARP-1
A recombinant fragment of PARP-1 (Meisterernst et al.,
1997), consisting of the DNA binding domain (amino
acids 1–450), was able to substitute for purified PARP-1
in Tax-activated, in vitro transcription (Anderson et al.,
2000). To test the coactivator function of full-length re-
combinant PARP-1, a 6-His tagged clone of PARP-1 (Oei
et al., 1996) was expressed in Escherichia coli and puri-
fied by NTA–agarose and hydroxyapatite chromatogra-
phy. This protein was tested in a highly purified transcrip-
tion system where PARP-1 was not detectable in any of
the fractions by Western blotting (data not shown). As
expected, full-length recombinant PARP-1 could substi-
tute for semipurified PARP-1 (Fig. 2) and highly purified
PARP-1 (Anderson et al., 2000 and data not shown),
indicating that expression of this PARP-1 clone in E. coli
yields a protein with coactivator function, while control
protein (BSA) did not substitute for PARP-1 function. Sur-
prisingly, reactions were inhibited by Tax (6.6-fold de-
crease) using this system in the absence of PARP-1.
Since Tax can partially function in vivo in the absence of
PARP-1, it is possible that other factors in the mouse
embryonic fibroblasts can partially substitute for PARP-1.
Furthermore, without PARP, Tax and CREB may form
FIG. 1. PARP-1 enhances Tax-activated transcription in vivo. (A) Anti-PARP-1 and anti-Beta-actin Western blot of whole-cell lysates from mouse
embryonic fibroblast cell line deficient for PARP-1 (/), a strain-matched wild-type cell line (/), and a line (A4) derived from the / cells with
the human PARP-1 cDNA stably introduced. The PARP-1 and actin bands are indicated. (B) The mouse embryonic cell line deficient for PARP-1 (PARP
/) and a PARP-1/ cell line that expresses human PARP-1 (A4) were transfected with a luciferase reporter plasmid driven by the HTLV-I promoter
(sequences 306 to 1) alone, or with a Tax expression vector. Additional pUC DNA was added to bring the total DNA to 25 g. Luciferase activity
was normalized to a control Renilla luciferase gene driven by the SV40 promoter and averaged for three replicates. Error bar represents the standard
deviation for each average.
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nonproductive complexes on the promoter (see below).
Full-length recombinant PARP-1 and a partially purified
PARP-1 fraction each restored Tax-activated transcription
to similar levels ( threefold). PARP-1 therefore contrib-
utes a combined 20-fold difference in Tax function when
both the anti-repression and the restoration of activation
by Tax are considered.
Sequence-specific binding of PARP-1 to the TxRE
To investigate the mechanism of PARP-1 coactivation
of Tax-activated transcription, we decided to test the
hypothesis that PARP-1 can interact directly with the
Tax–CREB–DNA complex. Since PARP-1 binds nonspe-
cifically to DNA ends, experiments with the Tax–CREB–
DNA complex require a modified TxRE probe. Comple-
mentary 5-biotinylated oligonucleotides were annealed
and purified. Double-stranded, end-blocked TxRE probes
were generated by binding streptavidin to the biotinyl-
ated ends. This strategy prevents binding of another
nonspecific end-binding protein, Ku, to DNA and the
TxRE (Yoo et al., 1999, and Z. Zhang and M. G. Anderson,
unpublished observations). Reactions with native PARP-1
(Fig. 3A) generated a more slowly migrating complex,
indicating that PARP-1 could bind to the end-blocked
probe (Fig. 3B).
To determine whether this binding was sequence-
specific, unlabeled, end-blocked oligonucleotides repre-
senting the TxRE, the MCAT1 element, and a completely
unrelated sequence were added to the binding reac-
tions. The unlabeled TxRE efficiently competed for bind-
ing as expected (Fig. 3B); however, up to 250-fold molar
excess of MCAT1 element (Fig. 3B), or an unrelated
sequence (data not shown), did not compete for binding.
Binding of PARP-1 to the TxRE was not competed with
25-fold molar excess of nonspecific oligonucleotides that
were not biotinylated (had free ends); however, 40 ng
dIdC interferes with binding (data not shown). Experi-
ments with full-length recombinant PARP-1 (Fig. 4 and
data not shown) and recombinant PARP-1 1–450 N-ter-
minal fragment (Figs. 3C and 3D) gave similar results.
This indicates that this internal, sequence-specific bind-
ing activity is located within or near the nonspecific DNA
binding domain of PARP-1 and is not due to binding at
DNA ends or nicks. Titration of recombinant PARP-1 in
binding reactions determined an approximate dissocia-
tion constant of 1 nM for this preparation of recombinant
PARP-1. Using the same approach, a second preparation
had an approximate dissociation constant of 9 nM (see
Materials and Methods).
Next we tested the effect of PARP-1 on Tax–CREB–
TxRE complexes. CREB bound to the streptavidin-
blocked probe. The addition of Tax to binding reactions
generated a slightly more slowly migrating complex as
has been previously observed (Anderson and Dynan,
1994), and the addition of PARP-1 led to an even slower
complex (indicated by the arrowheads in Fig. 3E), con-
sistent with a complex of Tax, CREB, and PARP-1 bound
to the TxRE.
To map the DNA sequence requirements for PARP-1
binding, we generated a series of double-stranded mu-
tant, biotinylated TxRE oligonucleotides (Fig. 4A) that
could be end-blocked. In competition gel shifts, mutant
m1 failed to compete for binding, even when present at
270-fold molar excess compared to the labeled TxRE
(Fig. 4B). A less severe mutation to the same region, m2,
also failed to compete at low concentrations; however, at
higher concentrations (270-fold excess), it competed. In-
terestingly, competition with a 90-fold excess of m2 gave
a complex with intermediate mobility. One possible ex-
planation is that PARP-1 binds efficiently as a dimer, and
the faster migrating complex is a TxRE/PARP-1 monomer
complex. Indeed, there is evidence that PARP-1 may
homodimerize through a leucine zipper motif (Uchida et
al., 1993). From the m1 and m2 competition experiments,
we conclude the following order of binding affinities for
PARP-1: TxRE  m2  m1. Internal DNA binding by
PARP-1 to matrix attachment DNA sequences has re-
cently been described (Galande and Kohwi-Shigematsu,
1999). However, this binding is to an AT-rich, base-un-
FIG. 2. Recombinant PARP-1 can substitute for purified PARP-1 frac-
tion. (A) Linear PhosphorImager analyses from representative in vitro
transcription experiments are shown, with an arrow indicating the
transcript. Reactions contain highly purified transcription factors with
Tax and PARP-1 added as indicated. PARP-1 in lanes 3 and 4 are from
one fraction while PARP-1 in lanes 5 and 6 are from the adjacent
fraction. (B) For the two experiments in A, Tax activation is plotted as
the average fold activation from two sets of reactions for no PARP-1
(lanes 1 and 2 and data not shown) and each PARP-1 source (lanes 3–6
and lanes 7–10) in A.
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pairing region, which readily unwinds under negative
torsional stress (Galande and Kohwi-Shigematsu, 1999).
Our critical region is not AT-rich; however, it overlaps the
CREB binding site (indicated as the CRE in Fig. 4A),
which is an imperfect palindrome. Our mutations main-
tain the imperfect palindrome, indicating that a palin-
drome is not sufficient for PARP-1 binding. A severe
mutation just outside of this region, m3, competes effi-
ciently for binding, as do mutations within and outside of
the CRE (m4, m5, and m6, Figs. 4B and 4C). From our
experiments, we conclude that sequences at the outer
edges of the CRE are critical for sequence-specific bind-
ing of PARP-1 to the HTLV-I TxRE.
PARP-1:TxRE binding in vivo
To assay for PARP-1:TxRE interactions in live cells, we
constructed a plasmid that expresses the DNA binding
domain of PARP-1 fused to the transcriptional activation
domain of the herpesvirus VP16 protein (PARP(1–450)VP16,
Fig. 5A). If the DNA binding domain of PARP-1 interacts
with the TxREs, it will bring the VP16 activation domain to
the promoter, which can then directly activate transcrip-
tion. To eliminate background binding from endogenous
PARP-1, this plasmid was tested in the PARP-1 /
mouse embryonic fibroblast cell line. The expression
plasmid was transiently cotransfected with a reporter
construct consisting of the HTLV-I promoter upstream of
the luciferase gene (306:Luc, Fig. 5B). One, two, and
four micrograms of PARP(1–450)VP16 led to similar in-
creases in transcription from the HTLV-I promoter, while
additional expression vector led to lower activation (Fig.
5C and data not shown). Similar amounts of PARP(1–450)
without the VP16 activation domain actually led to a
slight decrease in expression from the 306:Luc con-
struct, and Tax, in the absence of PARP-1, activated
transcription about 18-fold as before (Fig. 5C and data
not shown). This slight decrease in activity with the
PARP-1 DNA binding domain alone is consistent with
previous in vitro transcription results (Anderson et al.,
2000), indicating that expression of the PARP-1 DNA
binding domain alone is insufficient for activation.
Several additional control experiments were per-
formed. Activity from a control construct, 52:Luc, con-
taining only the HTLV-I core promoter (52 to1) and no
FIG. 3. Binding assays with PARP-1 and end-blocked probes. (A) Coomassie-stained gel of PARP-1 (indicated by arrow) purified from HeLa cells
(native) and recombinant PARP-1 (rec.). Size of molecular weight markers (M) is indicated on the left. (B) End-blocked 2 (SA): DNA gel shift with native
PARP-1. Unlabeled, end-blocked double-stranded oligonucleotides (TxRE, MCAT1) were added as competitors, with the molar ratio of competitor to
probe shown above. PARP-1 bound to 2(SA): DNA complex migrates slightly more slowly and is indicated by the arrow. Probe is labeled wild-type
TxRE. (C) Coomassie-stained gel of fractions from the purification of recombinant PARP-1 (amino acids 1–450), indicated by arrow. Fraction 37 was
used in an end-blocked gel shift assay (D), with conditions identical to (B). (E) Recombinant CREB, Tax, and PARP-1 (amino acids 1–450) were added
to binding reactions as indicated. Complexes are indicated by the arrowheads on the left.
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TxREs, was not stimulated by PARP(1–450)VP16 (Fig. 5D),
indicating the requirement of the region containing the
TxREs for in vivo binding. Addition of 1, 2, 4, or even 8
micrograms of the PARP(1–450)VP16 did not have a signif-
icant effect on luciferase constructs driven by either the
promoter for c-Fos or the SV40 virus constructs (Fig. 5D
and data not shown). That the c-Fos promoter was not
responsive was initially somewhat surprising, since it
has a CRE; however, this CRE is considerably different
from the TxRE to which PARP-1 binds (discussed below).
These experiments indicate that in vivo, PARP-1 can be
recruited specifically to the HTLV-I promoter in the region
containing the TxREs.
Since the cytomegalovirus immediate-early (CMV IE)
promoter contains four CREs, we next tested for activa-
tion of the CMV IE promoter by PARP(1–450)VP16. We found
that addition of 4 or 8 micrograms of PARP(1–450)VP16
expression vector activated expression from the CMV
promoter up to sixfold (Fig. 6A). A comparison of the
sequences critical for in vivo recruitment of PARP-1 to the
promoter is shown in Fig. 6B. The competition gel shift
data indicated that mutation of sequences within and
just adjacent to the CRE in the TxRE leads to loss of
PARP-1 binding (Fig. 4). Our in vivo data are consistent
with the binding data, as the c-Fos promoter, which was
not responsive to PARP(1–450)VP16, has significant differ-
ences at nucleotides found to be critical for binding in
vitro (four of eight nucleotides, indicated by the aster-
isks). Conversely, the CMV IE promoter, which was re-
sponsive to PARP(1–450)VP16, has CREs that are almost
identical to the HTLV-I CREs (differences at only one of
eight nucleotides). These data are consistent with in vivo
recruitment of PARP-1 to the TxRE of the HTLV-I promoter
as well as the CMV IE promoter, which is also Tax-
responsive (Moch et al., 1992).
DISCUSSION
PARP-1 has recently been demonstrated to be a coac-
tivator for transcription in experimental systems and in
the context of several natural promoters. PARP-1 was
identified as the coactivator activity PC1 for model pro-
teins containing the NF-B and GAL4 acidic activation
domain fused to the GAL4 DNA binding domain (Meister-
ernst et al., 1997). PARP-1 activity has also been impli-
cated in inhibiting transcription, including the activity of
certain nuclear receptors, as well as the transcription
factors TBP, YY1, and Sp1 (Miyamoto et al., 1999; Oei et
FIG. 5. Recruitment of PARP-1 to the TxREs in the HTLV-I promoter in
live cells. (A) Effectors are a fusion protein of the PARP-1 DNA binding
domain and VP16, or the DNA binding domain of PARP-1 only. (B)
Diagram of reporter constructs tested. (C) Ten micrograms of promoter-
luciferase constructs were transfected into PARP-1 / cells with
either 1 g pUC DNA or 1 g PARP(1–450)VP16 expression vector. (D)
Four micrograms of PARP(1–450)VP16 expression vector was transfected
with 10 g of the reporter construct indicated. Activation was deter-
mined by dividing luciferase activity in the presence of the PARP-1
expression vector by activity in the absence of PARP-1 expression
vector. For (C) and (D), the error bar indicates standard deviation.
Data are representative of several independent experiments with
PARP(1–450)VP16 expression vector amounts from 1 to 8 g.
FIG. 4. Competition experiments with mutant TxREs. (A) Wild-type
(wt) and mutant (m1–m6) competitor sequences are indicated with
nucleotide changes shown (F indicates same nucleotide as in TxRE).
Ability to function as a competitor at low concentrations in (B) is
indicated on the right. (B and C) Shown is an end-blocked (2SA) gel
shift with full-length recombinant PARP-1. Competition experiments
were performed as in Fig. 3.
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al., 1998a,b). In addition, PARP-1 has been shown to
contribute to transcriptional activation by AP-2, NF-B,
and B-MYB, in the absence of NAD (Cervellera and
Sala, 2000; Kannan et al., 1999; Oliver et al., 1999).
PARP-1 contributes to stimulation of transcription from
the E2F-1 (Simbulan-Rosenthal et al., 1999), Pax-6 (Plaza
et al., 1999), CXCL1 (Nirodi et al., 2001), and Reg promot-
ers (Akiyama et al., 2001), and promoters with MCAT1
sites (Butler and Ordahl, 1999). For some of these coac-
tivator functions, PARP-1 is believed to function by pro-
tein–protein interactions. PARP-1 has been demon-
strated to form ternary complexes with transcription fac-
tors and DNA elements, such as with TEF-1 at the
MCAT1 sites (Butler and Ordahl, 1999; Vyas et al., 2001),
and even to DNA alone, such as the IUR of the CXCL1
gene (Nirodi et al., 2001), and a region of the Reg pro-
moter (Akiyama et al., 2001). In addition, PARP-1 has
been shown to bind directly to transcription factors such
as YY1, Oct-1, Max, and p53 (Malanga et al., 1998; Nie et
al., 1998; Oei et al., 1997; Uchida et al., 1993; Vyas et al.,
2001). Our data demonstrate a direct, sequence-specific
binding activity of PARP-1 to a region partially overlap-
ping the CRE in the TxRE. Specifically, the sequences
TTGAxxACAA are critical for PARP-1 binding. Other
PARP-1 binding sequences have only a few nucleotides
in common: the MCAT-1 site (CAAGTGTTGCATTC-
CTCTCTG, core in bold) has a TTG, while the cis-element
of the Reg gene (TGCCCCTCCCAT), the IUR (TCGATCT-
GGAACTCC), and the matrix attachment sequence (Ga-
lande and Kohwi-Shigematsu, 1999) (TCTTTAATTTCTA-
ATATATTTAG) have nothing more than dinucleotide
matches. Furthermore, the MCAT-1 site failed to compete
for binding at 250-fold molar excess, suggesting either
that the TxRE binds significantly better or that binding
occurs via some other noncompetitive mechanism.
Using deletion analysis of PARP-1, we found that the
TxRE binding activity of PARP-1 localizes to the same
region of PARP-1 as the nonspecific DNA binding do-
main, amino acids 1–450. This region contains two zinc
finger domains required for binding to DNA strand
breaks (Gradwohl et al., 1990); however, it was reported
that mutants that lack both zinc fingers weakly bound
DNA internally (Ikejima et al., 1990). We found that bind-
ing of PARP-1 to the TxRE could not be competed with a
25-fold molar excess of nonspecific oligonucleotides
with free ends; however, 40 nanograms dIdC could com-
pete. This could be due to either the DNA end-binding
site being identical to the TxRE-binding site or the two
sites being so close that occupation of the end-binding
site interferes with the TxRE-binding site. These data are
consistent with a previous report of an internal DNA
binding activity that is weaker than the strong, nonspe-
cific DNA break binding activity, which is independent of
the zinc fingers (Ikejima et al., 1990).
We were able to demonstrate in vivo binding of PARP-1
to the TxREs as well as to the CMV promoter using a
“one-hybrid” approach. The VP16 activation domain was
fused to the PARP-1 DNA binding domain, and expres-
sion of this fusion protein specifically activated transcrip-
tion from TxRE-containing promoters, HTLV-I and CMV.
The activation was significant, between 4- and 6-fold in
most experiments and as high as 11-fold in others (data
not shown), despite possible competition from other fac-
tors that bind to the TxREs (Beraud et al., 1991; Jeang et
al., 1988; Lombard-Platet and Jalinot, 1993; Marriott et al.,
1990; Nyborg and Dynan, 1990; Poteat et al., 1990; Tan et
al., 1989; Tsujimoto et al., 1991; Xu et al., 1990; Yoshimura
et al., 1990; Zhao and Giam, 1991). Our observed activa-
tion is similar to the 3.5- to 4.0-fold activation of a CRE-
containing promoter construct by a CREB–VP16 fusion
protein in cultured cortical neurons (Tao et al., 1998), and
the 3.5- to 6.0-fold activation of several other CRE-con-
taining promoter constructs by CREB–VP16 in 3T3-L1
cells (Reusch et al., 2000). It was particularly interesting
that another TxRE/CRE-containing promoter, c-Fos, was
not stimulated by PARP(1–450)VP16. This could be due to
differences in the c-Fos CRE compared to the HTLV-I
TxRE and the CMV CRE at the critical residues identified
in our binding experiments (see Fig. 6). Our model pre-
dicts that mutating the c-Fos CRE to mimic the sequence
of the TxRE would confer responsiveness to
PARP(1–450)VP16. The PARP(1–450)VP16 fusion protein is a
useful tool for identifying promoter elements that interact
with PARP-1.
PARP-1 is expressed in most tissues; however, expres-
sion is low in resting T cells. Activated T cells have
FIG. 6. DNA sequences critical for PARP-1 binding. (A) Human CMV
promoter-luciferase construct was cotransfected with indicated
amounts of PARP(1–450)VP16 and activity was determined as in Fig. 5.
Sequences of probes used in end-blocked, gel-shift assays are shown
in (B) compared to the CREs from the c-Fos and CMV promoters. Dots
indicate sequences identical to the wild-type TxRE; asterisks indicate
the changes at critical oligonucleotides.
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significantly elevated PARP-1 expression (McNerney et
al., 1989; Menegazzi et al., 1988). Infection of T cells by
HTLV-I leads to activation of T cells, potentially increas-
ing PARP-1 expression (Feuer and Chen, 1992). There-
fore, elevated levels of PARP-1 are expected during the
course of HTLV-I infection. In addition, a PARP-1 associ-
ated kinase has been found in HTLV-I infected cell lines,
but not uninfected lines. It is therefore possible that
infection of T cells by HTLV-I alters the normal functions
of PARP-1, including the positioning of PARP-1 on the
HTLV-I promoter to enhance transcription.
PARP-1 may function as a coactivator by several dif-
ferent mechanisms, with different requirements for poly-
(ADP-ribosylation) activity. Our in vitro findings indicate
that PARP-1 functions in the absence of NAD and the
DNA binding domain alone is sufficient for coactivator
activity, indicating that poly(ADP-ribosylation) activity is
not necessary for function (Anderson et al., 2000). Tax
activation in vivo is enhanced by the inhibition of poly-
(ADP-ribosylation) activity (M. G. Anderson, unpublished
observation), and PARP-1 activity affects CREB–DNA in-
teractions (Oei et al., 1998a). We can infer that poly(ADP-
ribosylation) can either directly or indirectly diminish Tax
function. Furthermore, Tax may be a target for poly(ADP-
ribosylation) (C. M. Simbulan-Rosenthal, unpublished ob-
servation). We therefore propose a model where PARP-1,
along with CREB, Tax, or both CREB and Tax, is bound to
the HTLV-I promoter on the TxREs (Fig. 7). While the
Tax/CREB/PARP-1 complex on the TxRE is detectable, it
is unclear at this point if both PARP-1 and CREB can bind
to the TxRE at the same time, or if these complexes are
formed through protein–protein interactions between
PARP-1 and CREB or Tax. These complexes could func-
tion by directly interacting with general transcription fac-
tors or RNA polymerase II to activate transcription, by
interacting with other transcription factors or additional
coactivators such as the CREB binding protein, CBP, or
by stabilizing or altering Tax/CREB complexes on the
promoter directly through protein–protein interactions.
Transcriptional activation by these complexes is attenu-
ated by PARP-1 poly(ADP-ribosylation) activity, possibly
through modification of PARP-1, Tax, CREB, or other gen-
eral transcription factors such as TBP and TFIIF (Oei et
al., 1998a; Rawling and Alvarez-Gonzalez, 1997). Future
experiments should investigate which complexes are the
most transcriptionally active, how these complexes en-
hance transcription, and what is the role of PARP-1 poly-
(ADP-ribosylation) in Tax activation. Our observations
identify a novel interaction between PARP-1 and the
TxRE, implying that recruitment of PARP-1 to the HTLV-I
promoter contributes to Tax activation.
MATERIALS AND METHODS
Plasmids
For the PARP(1–450)VP16 clone, the following oligonucle-
otides were synthesized for PCR: upstream primer, 5-
GCTCTAGACAATTGCATATGGCGGAGTATTAGGATAAGC-3
(with anMfeI site and the ATG start site underlined); down-
stream primer, 5-TACGCGTCGACAGGTTGGCTTCCTT-
TACTTC-3 (with the SalI site underlined). The latter primer
corresponds to nucleotides 1335–1350. PCR was carried
out, using standard conditions, to generate a product of 1.4
kb in length. DNA was gel-purified, digested with MfeI and
SalI, and ligated into the pTet-off vector (Clontech), which
had been digested with EcoRI and SalI. This inserted the
PARP-1 DNA binding domain (amino acids 1–450) in frame
with the VP16 activation domain. For the PARP(1–450) clone, a
second downstream primer, 5-TACGCGTCGACTTAGTTG-
GCTTCCTTTACTTC-3, was used with the upstream primer
to create an identical fragment except for an in-frame stop
codon (underlined) that terminated translation after amino
acid 450 of PARP-1. This fragment was similarly cloned into
the EcoRI and SalI sites of pTet-off. Construction of the
HTLV-I promoter construct 306:Luc has been previously
described (Anderson et al., 2000). The52:Luc construct is
identical except that it is missing nucleotides306 to53
of the HTLV-I promoter. Additional plasmids include SV40
Luciferase (pGL2-Promoter, Promega, Madison, WI),
SV40RL (Promega), CMV:Luciferase (a gift from Dr. Cecilia
Lo), and cFos:Luciferase (a gift from Dr. Nahid Mivechi).
Cell lines
The mouse embryonic fibroblast cell line from the
PARP-1 “knockout” mouse with a targeted disruption in
exon 2 was a generous gift from Dr. Z. Q. Wang and has
been described elsewhere (Wang et al., 1995). Cells
were maintained and transfected as previously de-
scribed (Anderson et al., 2000). To generate the mouse
PARP-1 / cell line that stably expresses a cDNA of
human PARP-1, pcD-12 (Alkhatib et al., 1987) was co-
transfected with pBABE (Morgernstern and Hartmut,
FIG. 7. Model for PARP-1 binding and coactivation of transcription.
For activation of transcription, PARP-1 forms complexes on the TxRE
either alone or with Tax and CREB. Poly(ADP-ribosylation) activity by
PARP-1 leads to a decrease in transcription. Poly(ADP-ribosylation) of
Tax, CREB, PARP-1, other transcription factors, general transcription
factors (such as TBP and TFIIF), or histones could lead to down-
regulation of HTLV-I expression.
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1990), for puromycin resistance, into PARP-1 / cells.
Cells were plated and colonies resistant to 2 g/ml
puromycin were isolated, grown, and tested for PARP-1
expression by Western blotting. The rabbit polyclonal IgG
against PARP-1, H-250 (Santa Cruz Biotechnology, Inc.,
Santa Cruz, CA), which is reactive to the carboxyl termi-
nal of both human and mouse PARP-1, was used for
Western blotting. PARP-1 reactivity was detected by the
ECF reagent (Amersham Pharmacia Biotech, Piscat-
away, NJ) according to the manufacturer’s instructions
and visualized by PhosphorImager analysis. Cells were
transfected and analyzed for luciferase activity as previ-
ously described (Anderson et al., 2000).
In vitro transcription and preparation of proteins
Purified epitope-tagged TFIID, RNA polymerase II,
Large Tax factor 1, Small Tax factor, and recombinant
TFIIA, TFIIB, TFIIE, and TFIIF were prepared as previ-
ously described (Anderson et al., 2000). Full-length re-
combinant PARP-1 (a generous gift from Dr. Shiao Li Oei)
was prepared as previously described (Oei et al., 1996),
except that after Ni-column chromatography, PARP-1
fractions were subjected to hydroxyapatite chromatogra-
phy as previously described (Anderson et al., 2000).
Bovine serum albumin (BSA) was added to normalize the
amount of total protein present in in vitro transcription
reactions with and without PARP-1. Purification of
rPARP-1 1–450, “native” PARP-1, and in vitro transcription
assays were carried out as previously described using
the 4 TxRE G-less cassette plasmid (Anderson et al.,
2000) and 25–50 ng of native PARP-1 or 240 ng of recom-
binant PARP-1.
Electrophoretic mobility shift assays
The following oligonucleotides (Life Technologies,
Rockville, MD) were generated for the wild-type TxRE
probe: “top-strand” 5-CTCAGGCGTTGACGACAACCCCT-
3, and “bottom strand” 5-GAGGGGTTGTCGTCAACGC-
CTGAG-3. The 5-most nucleotide was synthesized us-
ing a biotinylated nucleotide. The bottom strand is com-
plementary to the top strand except for an additional G at
the 3 end for labeling. Complementary oligonucleotides
were heated to 98°C, slow-cooled to anneal, and gel
purified in a 12% polyacrylamide gel. The wild-type probe
was labeled by incubation in the presence of the Klenow
fragment of DNA polymerase I (Promega) with
-[32P]dCTP (New England Nuclear, Boston, MA), as
specified by the manufacturer. Excess -[32P]dCTP was
removed by a G-25 spin column (5 Prime 3 3 Prime,
Boulder, CO). Mutant oligonucleotides (sequences de-
scribed in the figures) were prepared in the same man-
ner, except that nonradioactive dCTP was substituted for
-[32P]dCTP. The MCAT1 competitor top strand is 5-
TGCAAGTGTTGCATTCCTCTCTG-3 and the unrelated
competitor top strand is 5-TGGTCGTATCTTCACCG-
TATCTG-3. For binding assays, 45 fmol labeled probe
(alone or with 0.45–12.15 pmol of unlabeled competitor
oligonucleotide) was mixed with 50 pmol streptavidin
(Sigma, St. Louis, MO) and incubated at room temper-
ature for 5 min. Binding assays (20 l total) were
carried out under the following conditions: 12.5 mM
HEPES (pH 7.9), 15 mM MgCl2, 0.5 mM EDTA, 50 mM
KCl, 2 mM -mercaptoethanol, 0.05% (v/v) NP-40, and
7.5% (v/v) glycerol. Titration experiments indicated that
35 fmol PARP-1 bound about half (22.5 fmol) of the
probe (45 fmol total) in a 20 l reaction. Using the
formula Kd  [PARPfree]  [probefree]/[PARP:probebound],
the estimated dissociation constant is 1 nM. Since 70
fmol routinely bound all of the probe, 70 fmol was used
for all subsequent binding experiments with this prep-
aration of PARP-1. Streptavidin-bound DNA mixtures
were added to tubes with PARP-1 and incubated for an
additional 10 min at room temperature. Binding reac-
tions were electrophoresed through a 4% nondenatur-
ing polyacrylamide gel (39:1 acrylamide:N,N-methyl-
ene-bis-acrylamide) in TB buffer, 45 mM Tris, and 45
mM borate (pH 8.0). DNA complexes were visualized
by PhosphorImager analysis.
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